The remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia
Susanna Esposito1, Alberto Argentiero1, Francesca Rebecchi1
1Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.
Insights
Optimizing antibiotic use in pediatric community-acquired pneumonia (CAP) remains a challenge. Shorter antibiotic courses, around 5 days, appear effective for mild to moderate CAP, with further improvements possible through physician education and advanced diagnostics.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial stewardship
- Respiratory medicine
Background:
- Current guidelines for pediatric community-acquired pneumonia (CAP) do not fully address challenges in antibiotic use.
- Inappropriate antibiotic prescribing, including unnecessary use and incorrect drug selection, is prevalent in pediatric CAP cases.
Purpose of the Study:
- To discuss unresolved issues in rational antibiotic therapy for pediatric CAP.
- To provide expert perspectives on improving antibiotic use in pediatric CAP management.
Main Methods:
- Expert review and discussion of current challenges in pediatric CAP antibiotic therapy.
- Analysis of existing evidence regarding antibiotic treatment duration and efficacy.
Main Results:
- Evidence suggests that a short antibiotic course of approximately 5 days is effective for mild to moderate pediatric CAP.
- Short-course antibiotic therapy yields comparable outcomes to prolonged courses in less severe cases.
Conclusions:
- Enhanced physician education on antibiotic use is crucial for improving pediatric CAP management.
- Adoption of point-of-care testing and new technologies like artificial intelligence can aid in determining infection etiology.
- Optimal antibiotic duration for pediatric CAP requires further research, especially considering bacterial etiology, disease severity, and patient characteristics.
Introduction:
Despite availability of several official guidelines, not all the problems related to the most effective and safe use of antibiotics in children with community-acquired pneumonia (CAP) have been solved. Presently, too many children receive unneeded antibiotics or, when antibiotics are mandatory, the choice of the drug is not appropriate.
Areas Covered:
In this paper, the authors discuss the remaining unsolved problems for rational antibiotic therapy use in pediatric community-acquired pneumonia and provide their expert perspectives.
Expert Opinion:
Further improvement in pediatric CAP management could be derived from physician education on antibiotic use and a larger use, particularly in office practice, of point of care testing or new technologies (i.e. artificial intelligence) to define etiology of a lower respiratory infection. However, recommendations regarding the duration of antibiotic therapy vary largely because of the absence of reliable data on the optimal CAP treatment according to the bacterial etiology of the disease, its severity, and child characteristics. Available evidence seems to confirm that a short course of antibiotics, approximately 5 days, can be effective and lead to results not substantially different from those obtained with prolonged-course antibiotic therapy, at least in patients with mild to moderate disease.
More Related Videos
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:30Pneumonia III: Complications and Assessment
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
01:27Combined Effects of Drugs: Synergism
Such synergistic combinations...